Moreover, invasiveness assay and MTT assay revealed that Cisplatin inhibited the invasion and growth of ESCC cells, and ATF3 knockdown was able to partially reverse this inhibition (Figure 7D, 7E and 7F). Here, ATF3 is linked to esophageal squamous cell carcinoma.